Autologous T-cell activation fosters ABT-199 resistance in chronic lymphocytic leukemia: rationale for a combined therapy with SYK inhibitors and anti-CD20 monoclonal antibodies

被引:14
作者
Enrique Elias, Esteban [1 ]
Belen Almejun, Maria [1 ,2 ]
Colado, Ana [1 ]
Cordini, Gregorio [1 ,3 ]
Vergara-Rubio, Maricef [1 ]
Podaza, Enrique [1 ]
Risnik, Denise [1 ,4 ]
Cabrejo, Maria [5 ]
Fernandez-Grecco, Horacio [5 ]
Fernando Bezares, Raimundo [6 ]
del Rosario Custidiano, Maria [7 ]
Cesar Sanchez-Avalos, Julio [7 ]
Vicente, Angeles [8 ]
Martin Garate, Gonzalo [8 ]
Borge, Mercedes [1 ,4 ]
Giordano, Mirta [1 ,4 ]
Gamberale, Romina [1 ,4 ]
机构
[1] ANM, CONICET, Inst Med Expt IMEX, Lab Inmunol Oncol, Buenos Aires, DF, Argentina
[2] Univ Buenos Aires, Fac Ciencias Exactas & Nat, Dept Fisiol Biol Mol & Celular, Buenos Aires, DF, Argentina
[3] Univ Buenos Aires, Hosp Clin Jose San Martin, Buenos Aires, DF, Argentina
[4] Univ Buenos Aires, Fac Med, Dept Microbiol Parasitol & Inmunol, Buenos Aires, DF, Argentina
[5] Sanatorio Municipal Dr Julio Mendez, Buenos Aires, DF, Argentina
[6] Hosp Gen Agudos Dr Teodoro Alvarez, Buenos Aires, DF, Argentina
[7] Inst Alexander Fleming, Buenos Aires, DF, Argentina
[8] Hosp Aleman, Buenos Aires, DF, Argentina
关键词
KINASE INHIBITORS; B-CELLS; CLL; ENTOSPLETINIB; VENETOCLAX; SIGNALS; GS-9973;
D O I
10.3324/haematol.2018.188680
中图分类号
R5 [内科学];
学科分类号
1002 ; 100201 ;
摘要
[No abstract available]
引用
收藏
页码:E458 / E461
页数:4
相关论文
共 15 条
[1]   Clinicopathological features and outcomes of progression of CLL on the BCL2 inhibitor venetoclax [J].
Anderson, Mary Ann ;
Tam, Constantine ;
Lew, Thomas E. ;
Juneja, Surender ;
Juneja, Manu ;
Westerman, David ;
Wall, Meaghan ;
Lade, Stephen ;
Gorelik, Alexandra ;
Huang, David C. S. ;
Seymour, John F. ;
Roberts, Andrew W. .
BLOOD, 2017, 129 (25) :3362-3370
[2]   BCR signaling inhibitors differ in their ability to overcome Mcl-1-mediated resistance of CLL B cells to ABT-199 [J].
Bojarczuk, Kamil ;
Sasi, Binu K. ;
Gobessi, Stefania ;
Innocenti, Idanna ;
Pozzato, Gabriele ;
Laurenti, Luca ;
Efremov, Dimitar G. .
BLOOD, 2016, 127 (25) :3192-3201
[3]   The kinase inhibitors R406 and GS-9973 impair T cell functions and macrophage-mediated anti-tumor activity of rituximab in chronic lymphocytic leukemia patients [J].
Colado, Ana ;
Belen Almejun, Maria ;
Podaza, Enrique ;
Risnik, Denise ;
Stanganelli, Carmen ;
Enrique Elias, Esteban ;
Dos Santos, Patricia ;
Slavutsky, Irma ;
Fernandez Grecco, Horacio ;
Cabrejo, Maria ;
Fernando Bezares, Raimundo ;
Giordano, Mirta ;
Gamberale, Romina ;
Borge, Mercedes .
CANCER IMMUNOLOGY IMMUNOTHERAPY, 2017, 66 (04) :461-473
[4]   Relationship between venetoclax exposure, rituximab coadministration, and progression-free survival in patients with relapsed or refractory chronic lymphocytic leukemia: demonstration of synergy [J].
Freise, Kevin J. ;
Jones, Aksana K. ;
Menon, Rajeev M. ;
Verdugo, Maria E. ;
Humerickhouse, Rod A. ;
Awni, Walid M. ;
Salem, Ahmed Hamed .
HEMATOLOGICAL ONCOLOGY, 2017, 35 (04) :679-684
[5]  
Ghia P, 2002, EUR J IMMUNOL, V32, P1403, DOI 10.1002/1521-4141(200205)32:5<1403::AID-IMMU1403>3.0.CO
[6]  
2-Y
[7]   The mechanism of anti-CD20-mediated B cell depletion revealed by intravital imaging [J].
Montalvao, Fabricio ;
Garcia, Zacarias ;
Celli, Susanna ;
Breart, Beatrice ;
Deguine, Jacques ;
Van Rooijen, Nico ;
Bousso, Philippe .
JOURNAL OF CLINICAL INVESTIGATION, 2013, 123 (12) :5098-5103
[8]   High-content screening identifies kinase inhibitors that overcome venetoclax resistance in activated CLL cells [J].
Oppermann, Sina ;
Ylanko, Jarkko ;
Shi, Yonghong ;
Hariharan, Santosh ;
Oakes, Christopher C. ;
Brauer, Patrick M. ;
Zuniga-Pflucker, Juan C. ;
Leber, Brian ;
Spaner, David E. ;
Andrews, David W. .
BLOOD, 2016, 128 (07) :934-947
[9]   T cells in chronic lymphocytic leukemia display dysregulated expression of immune checkpoints and activation markers [J].
Palma, Marzia ;
Gentilcore, Giusy ;
Heimersson, Kia ;
Mozaffari, Fariba ;
Nasman-Glaser, Barbro ;
Young, Emma ;
Rosenquist, Richard ;
Hansson, Lotta ;
Osterborg, Anders ;
Mellstedt, Hakan .
HAEMATOLOGICA, 2017, 102 (03) :562-572
[10]  
PIZZOLO G, 1983, BLOOD, V62, P1289